Effectual Labeling of Natural Killer Cells with Upconverting Nanoparticles by Electroporation for In Vivo Tracking and Biodistribution Assessment
Related Experiment Video
Updated: Dec 6, 2025

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
Published on: April 29, 2017
Hye Sun Park1, Jongwoo Kim2,3, Mi Young Cho1
1Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.
Abstract:
Natural killer (NK) cells, which are cytotoxic lymphocytes of the innate immune system and recognize cancer cells via various immune receptors, are promising agents in cell immunotherapy. To utilize NK cells as a therapeutic agent, their biodistribution and pharmacokinetics need to be evaluated following systemic administration. Therefore, in vivo imaging and tracking with efficient labeling and quantitative analysis of NK cells are required. However, the lack of the phagocytic capacity of NK cells makes it difficult to establish breakthroughs in cell labeling and subsequent in vivo studies. Herein, an effective labeling of upconverting nanoparticles (UCNPs) in NK cells is proposed using electroporation with high sensitivity and stability. The labeling performance of UCNPs functionalized with carboxy-polyethylene glycol (PEG) is better than with methoxy-PEG or with amine-PEG. The labeling efficiency becomes higher, but cell damage is greater as electric field increases; thus, there is an optimum electroporation condition for internalization of UCNPs into NK cells. The tracking and biodistribution imaging analyses of intravenously injected NK cells show that the labeled NK cells are initially distributed primarily in lungs and then spread to the liver and spleen. These advances will accelerate the application of NK cells as key components of immunotherapy against cancer.
Insights
Researchers developed a novel method to label natural killer (NK) cells for cancer immunotherapy. This technique enables effective tracking of these immune cells in vivo, advancing their therapeutic applications.
Area of Science:
- Immunology
- Biotechnology
- Nanotechnology
Background:
- Natural killer (NK) cells are crucial cytotoxic lymphocytes in innate immunity and show promise for cancer immunotherapy.
- Evaluating NK cell biodistribution and pharmacokinetics after systemic administration is essential for therapeutic development.
- The limited phagocytic capacity of NK cells poses challenges for efficient cell labeling and in vivo tracking.
Purpose of the Study:
- To develop an effective method for labeling NK cells with upconverting nanoparticles (UCNPs) for in vivo imaging and tracking.
- To optimize electroporation conditions for high-sensitivity and stable UCNP labeling of NK cells.
- To analyze the biodistribution and pharmacokinetics of UCNP-labeled NK cells following intravenous injection.
Main Methods:
- Electroporation was employed to introduce UCNPs into NK cells, with varying PEGylation strategies (carboxy-PEG, methoxy-PEG, amine-PEG) investigated.
- Optimization of electroporation parameters (electric field strength) was performed to balance labeling efficiency and cell viability.
- In vivo imaging and biodistribution studies were conducted after intravenous injection of UCNP-labeled NK cells in a preclinical model.
Main Results:
- Carboxy-PEG functionalized UCNPs demonstrated superior labeling performance compared to other PEGylation methods.
- An optimal electroporation condition was identified, maximizing UCNP internalization while minimizing NK cell damage.
- Biodistribution analysis revealed initial accumulation of labeled NK cells in the lungs, followed by distribution to the liver and spleen.
Conclusions:
- Electroporation provides an effective strategy for high-sensitivity and stable labeling of NK cells with UCNPs.
- Optimized UCNP labeling facilitates in vivo tracking and biodistribution assessment of NK cells for immunotherapy.
- These advancements are expected to accelerate the clinical application of NK cell-based cancer immunotherapies.

